GE HealthCare Technologies Inc. (NASDAQ:GEHC) CEO Roland Rott Sells 3,577 Shares

GE HealthCare Technologies Inc. (NASDAQ:GEHC) CEO Roland Rott sold 3,577 shares of the firm’s stock in a transaction on Wednesday, November 6th. The shares were sold at an average price of $86.48, for a total transaction of $309,338.96. Following the completion of the transaction, the chief executive officer now directly owns 24,298 shares of the company’s stock, valued at $2,101,291.04. This represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which can be accessed through this hyperlink.

GE HealthCare Technologies Stock Performance

Shares of NASDAQ:GEHC opened at $86.78 on Thursday. GE HealthCare Technologies Inc. has a 12-month low of $66.39 and a 12-month high of $94.55. The company’s 50 day moving average price is $88.74 and its two-hundred day moving average price is $83.46. The firm has a market cap of $39.65 billion, a PE ratio of 23.84, a PEG ratio of 3.12 and a beta of 1.24. The company has a quick ratio of 0.98, a current ratio of 1.23 and a debt-to-equity ratio of 1.12.

GE HealthCare Technologies (NASDAQ:GEHC) last posted its quarterly earnings data on Wednesday, October 30th. The company reported $1.14 EPS for the quarter, topping analysts’ consensus estimates of $1.06 by $0.08. The firm had revenue of $4.86 billion for the quarter, compared to analyst estimates of $4.87 billion. GE HealthCare Technologies had a return on equity of 25.19% and a net margin of 8.56%. The company’s revenue was up .9% on a year-over-year basis. During the same quarter last year, the company earned $0.99 EPS. Equities research analysts predict that GE HealthCare Technologies Inc. will post 4.29 earnings per share for the current year.

GE HealthCare Technologies Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Friday, November 15th. Investors of record on Friday, October 18th will be given a dividend of $0.03 per share. The ex-dividend date is Friday, October 18th. This represents a $0.12 annualized dividend and a yield of 0.14%. GE HealthCare Technologies’s dividend payout ratio is 3.30%.

Institutional Investors Weigh In On GE HealthCare Technologies

Large investors have recently bought and sold shares of the company. Janney Montgomery Scott LLC raised its position in GE HealthCare Technologies by 12.0% during the first quarter. Janney Montgomery Scott LLC now owns 45,895 shares of the company’s stock valued at $4,172,000 after purchasing an additional 4,913 shares in the last quarter. Mutual of America Capital Management LLC boosted its stake in GE HealthCare Technologies by 6.0% in the first quarter. Mutual of America Capital Management LLC now owns 55,651 shares of the company’s stock valued at $5,059,000 after buying an additional 3,146 shares in the last quarter. Chevy Chase Trust Holdings LLC grew its position in GE HealthCare Technologies by 7.1% in the first quarter. Chevy Chase Trust Holdings LLC now owns 235,436 shares of the company’s stock valued at $21,403,000 after acquiring an additional 15,522 shares during the last quarter. Texas Permanent School Fund Corp raised its stake in GE HealthCare Technologies by 8.3% during the first quarter. Texas Permanent School Fund Corp now owns 87,572 shares of the company’s stock worth $7,961,000 after acquiring an additional 6,738 shares in the last quarter. Finally, Grandfield & Dodd LLC lifted its holdings in shares of GE HealthCare Technologies by 5.6% in the first quarter. Grandfield & Dodd LLC now owns 315,685 shares of the company’s stock worth $28,699,000 after acquiring an additional 16,800 shares during the last quarter. 82.06% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

GEHC has been the topic of a number of research analyst reports. JPMorgan Chase & Co. initiated coverage on shares of GE HealthCare Technologies in a report on Monday, September 9th. They issued a “neutral” rating and a $90.00 target price on the stock. BTIG Research upgraded GE HealthCare Technologies from a “neutral” rating to a “buy” rating and set a $100.00 target price for the company in a research note on Wednesday, September 18th. Stifel Nicolaus boosted their target price on GE HealthCare Technologies from $100.00 to $102.00 and gave the stock a “buy” rating in a report on Monday, September 30th. Wells Fargo & Company raised their price target on GE HealthCare Technologies from $95.00 to $96.00 and gave the company an “overweight” rating in a report on Thursday, October 31st. Finally, Redburn Atlantic raised shares of GE HealthCare Technologies to a “strong-buy” rating in a research report on Thursday, August 1st. One analyst has rated the stock with a sell rating, five have given a hold rating, eight have given a buy rating and one has given a strong buy rating to the stock. Based on data from MarketBeat.com, the stock has an average rating of “Moderate Buy” and an average price target of $94.36.

GE HealthCare Technologies Company Profile

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.